These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 15001459)

  • 1. Effects of exogenous and endogenous natriuretic peptides on forearm vascular function in chronic heart failure.
    Schmitt M; Gunaruwan P; Payne N; Taylor J; Lee L; Broadley AJ; Nightingale AK; Cockcroft JR; Struthers AD; Tyberg JV; Frenneaux MP
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):911-7. PubMed ID: 15001459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial natriuretic peptide regulates regional vascular volume and venous tone in humans.
    Schmitt M; Broadley AJ; Nightingale AK; Payne N; Gunaruwan P; Taylor J; Lee L; Cockcroft J; Struthers AD; Frenneaux MP
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1833-8. PubMed ID: 12842844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasodilatory effects of C-type natriuretic peptide on forearm resistance vessels are distinct from those of atrial natriuretic peptide in chronic heart failure.
    Nakamura M; Arakawa N; Yoshida H; Makita S; Hiramori K
    Circulation; 1994 Sep; 90(3):1210-4. PubMed ID: 8087930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial NO/cGMP system contributes to natriuretic peptide-mediated coronary and peripheral vasodilation.
    Brunner F; Wölkart G
    Microvasc Res; 2001 Jan; 61(1):102-10. PubMed ID: 11162200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure.
    Nakamura M; Arakawa N; Yoshida H; Makita S; Niinuma H; Hiramori K
    Am Heart J; 1998 Mar; 135(3):414-20. PubMed ID: 9506326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular effects of natriuretic peptides in healthy men.
    Komarek M; Bernheim A; Schindler R; Steden R; Kiowski W; Brunner-La Rocca HP
    J Cardiovasc Pharmacol Ther; 2004 Dec; 9(4):263-70. PubMed ID: 15678245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct comparison of relaxation and cGMP production in human coronary by-pass grafts in response to stimulation with natriuretic peptides and a nitric oxide donor.
    Hammerer-Lercher A; Fersterer J; Holzmann S; Bonatti J; Ruttmann E; Hoefer D; Mair J; Puschendorf B
    Clin Sci (Lond); 2006 Sep; 111(3):225-31. PubMed ID: 16709152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inhibitor of inducible nitric oxide synthase decreases forearm blood flow in patients with congestive heart failure.
    Ishibashi Y; Shimada T; Murakami Y; Takahashi N; Sakane T; Sugamori T; Ohata S; Inoue S; Ohta Y; Nakamura K; Shimizu H; Katoh H; Hashimoto M
    J Am Coll Cardiol; 2001 Nov; 38(5):1470-6. PubMed ID: 11691525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors.
    Springer J; Azer J; Hua R; Robbins C; Adamczyk A; McBoyle S; Bissell MB; Rose RA
    J Mol Cell Cardiol; 2012 May; 52(5):1122-34. PubMed ID: 22326431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natriuretic peptides modulate nitric oxide synthesis in cytokine-stimulated cardiac myocytes.
    Yamamoto K; Ikeda U; Shimada K
    J Mol Cell Cardiol; 1997 Sep; 29(9):2375-82. PubMed ID: 9299361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic peptide preserves endothelial function during intimal hyperplasia.
    Barber MN; Gaspari TA; Kairuz EM; Dusting GJ; Woods RL
    J Vasc Res; 2005; 42(2):101-10. PubMed ID: 15665545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of natriuretic peptides in regulation of conduit artery distensibility.
    Schmitt M; Qasem A; McEniery C; Wilkinson IB; Tatarinoff V; Noble K; Klemes J; Payne N; Frenneaux MP; Cockcroft J; Avolio A
    Am J Physiol Heart Circ Physiol; 2004 Sep; 287(3):H1167-71. PubMed ID: 15317675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling.
    Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR
    Eur J Pharmacol; 2005 Mar; 510(3):209-15. PubMed ID: 15763244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure.
    Chen HH; Cataliotti A; Schirger JA; Martin FL; Burnett JC
    Am J Physiol Regul Integr Comp Physiol; 2005 May; 288(5):R1093-7. PubMed ID: 15627648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic peptides and their therapeutic potential.
    Cho Y; Somer BG; Amatya A
    Heart Dis; 1999; 1(5):305-28. PubMed ID: 11720638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slower onset of vasodilating action of brain natriuretic peptide (BNP) compared to atrial natriuretic peptide (ANP) in human forearm resistant vessels.
    Minami H; Yasu T; Tagawa T; Yamakawa K; Ueda S
    Eur J Clin Pharmacol; 2008 Sep; 64(9):859-62. PubMed ID: 18622600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nitric oxide inhibition on basal forearm blood flow in patients with nonischemic chronic heart failure.
    Yoshida H; Nakamura M; Akatsu T; Arakawa N; Hiramori K
    Heart Vessels; 1998; 13(3):142-6. PubMed ID: 10328184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal desmopressin-induced forearm vasodilatation in patients with heart failure: dependence on nitric oxide synthase activity.
    Rector TS; Bank AJ; Tschumperlin LK; Mullen KA; Lin KA; Kubo SH
    Clin Pharmacol Ther; 1996 Dec; 60(6):667-74. PubMed ID: 8988069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: novel cardioprotective role for endothelium-derived C-type natriuretic peptide.
    Hobbs A; Foster P; Prescott C; Scotland R; Ahluwalia A
    Circulation; 2004 Sep; 110(10):1231-5. PubMed ID: 15337698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.